I am glad to have found this website and I hope you can help me in this difficult decision we need to make.
My mother was diagnosed with active myeloma in September of 2015 at the age of 66. She is IgA and was classified high risk after a bone marrow biopsy was made which also showed over 50% involvement. Her monoclonal protein levels were at 50 g/L (5 g/dL).
She did not want to go for a transplant and the doctors did not necessarily encourage it here in Dubai.
She was first treated with Revlimid and dexamethasone, which gave good results and took her M-spike down to around 10 g/L (1 g/dL).
A few months later, the treatment started failing, and she switched to a new treatment regimen, Velcade in combination with cyclophosphamide and dexamethasone. That treatment brought her M-spike down to 0 and we had great hopes.
However, the treatment failed in May 2017 and she had a large bone lesion with excruciating pain in the hip. She underwent 10 sessions of radiotherapy, which relieved her pain.
The doctors first switched to Pomalyst (pomalidomide) and dexamethasone. Unfortunately, in August they found extramedullary plasmacytomas in her breast. So they added the new Darzalex (daratumumab), hoping that this triple combo would work.
Sadly, in October this year, they found numerous new plasmacytomas (near stomach, back, etc).
So the doctors are now asking her to make a choice among the following:
- Either go for a regular strong chemotherapy regimen once every 3 weeks. The doctors say this can help reduce the tumours but are uncertain if it is worth it due to the aggressiveness of the illness and the fact that all previous treatments have failed.
- Or the second option is to stop all treatments and just take 50 mg of cyclophosphamide every other day with some prednisone. This solution is the one they offer if she wishes to discontinue treatments and try to enjoy the time she has left.
Do you think the chemotherapy option can still work in her case or should we consider discontinuing and going for the second option?
Kind regards,
AngeliqueDubai